Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 9/20 | 0.71 |
| ▸ | CCKAR | P32238 | 6/20 | 0.71 |
| ▸ | SCN9A | Q15858 | 4/20 | 0.57 |
| ▸ | SENP1 | Q9P0U3 | 1/20 | 0.55 |
| ▸ | BRD4 | O60885 | 2/20 | 0.53 |
| ▸ | BRD2 | P25440 | 2/20 | 0.53 |
| ▸ | BRD3 | Q15059 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8585550 | 1.00 | CCKBR (0.71) | CCKBRCCKARSCN9ASENP1BRD4 | |
| SCHEMBL8667933 | 0.90 | CCKBR (0.62) | CCKBRCCKARSCN9ASENP1 | |
| SCHEMBL8537020 | 0.89 | CCKBR (0.72) | CCKBRCCKARSCN9A | |
| SCHEMBL8537024 | 0.89 | CCKBR (0.72) | CCKBRCCKARSCN9A | |
| SCHEMBL8939498 | 0.87 | SENP1 (0.73) | CCKBRCCKARSCN9ASENP1BRD4 | |
| SCHEMBL9865538 | 0.87 | SENP1 (0.73) | CCKBRCCKARSCN9ASENP1BRD4 | |
| SCHEMBL9866216 | 0.81 | CCKBR (0.76) | CCKBRCCKAR | |
| SCHEMBL9866172 | 0.81 | CCKBR (1.00) | CCKBRCCKAR | |
| SCHEMBL8773990 | 0.80 | CCKBR (0.82) | CCKBRCCKAR | |
| SCHEMBL8533593 | 0.80 | CCKBR (0.82) | CCKBRCCKAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5763437-A | Benzodiazepine derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-06-09 | — | — | US | disclosed |
| WO-1996004254-A2 | BENZODIAZEPINE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-02-15 | — | — | WO | disclosed |